HEALTHCARE RESOURCE UTILIZATION IN PATIENTS RECEIVING PEMBROLIZUMAB OR DOCETAXEL WITH PREVIOUSLY TREATED ADVANCED NSCLC

Author(s)

Huang M, Pellissier J, Liao J
Merck & Co., Inc., North Wales, PA, USA

Presentation Documents

OBJECTIVES:  The objective of this study was to evaluate healthcare resource utilization (HCRU) related to cancer management care within a clinical trial in advanced NSCLC patients who have experienced disease progression after platinum-containing chemotherapy. METHODS:  

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PCN258

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Oncology

Explore Related HEOR by Topic

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×